Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Sales | N/A | N/A | N/A | 2,760 | N/A |
| Gross Profit | N/A | N/A | N/A | 2,760 | N/A |
| Operating Expenses | 9,745 | 7,102 | 9,768 | 7,014 | 6,226 |
| Operating Income | -9,745 | -7,102 | -9,768 | -4,254 | -6,226 |
| Other Income | 270 | 118 | 163 | 78 | 180 |
| Pre-tax Income | -9,475 | -6,984 | -9,605 | -4,176 | -6,046 |
| Income Tax | -2,396 | -2,904 | -2,171 | -2,225 | -2,067 |
| Net Income Continuous | -7,080 | -4,080 | -7,434 | -1,951 | -3,979 |
| Minority Interests | 257 | N/A | N/A | N/A | N/A |
| Net Income | $-6,822 | $-4,080 | $-7,434 | $-1,951 | $-3,979 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.03 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.03 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.03 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.03 | -0.01 | -0.02 |
| EBITDA(a) | $-9,198 | $-6,972 | $-9,687 | $-4,199 | $-6,104 |